Literature DB >> 8104323

Expression pattern and pharmacology of the rat type IV metabotropic glutamate receptor.

P Kristensen1, P D Suzdak, C Thomsen.   

Abstract

The mRNA for the type IV metabotropic glutamate receptor (mGluR4) is most prominently expressed in cerebellar granule cells, the olfactory system, the lateral septal nucleus, and most thalamic nuclei, but lower amount of the mRNA is found in many different brain regions. Agonist stimulation as studied in transfected cells was found to inhibit forskolin-stimulated cyclic-adenosine-monophosphate formation through a pertussis toxin-sensitive mechanism. Agonist rank order of potencies was: L-2-amino-4-phosphonobutyrate (L-AP4) > glutamate > (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) > quisqualate > L-homocysteate = ibotenate. The results suggests that the mGluR4 may be responsible for many, but not all, effects of L-AP4.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104323     DOI: 10.1016/0304-3940(93)90697-j

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  A new signalling pathway for parallel fibre presynaptic type 4 metabotropic glutamate receptors (mGluR4) in the rat cerebellar cortex.

Authors:  Karine Abitbol; Heather McLean; Thomas Bessiron; Hervé Daniel
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

2.  [3H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a.

Authors:  L Eriksen; C Thomsen
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 3.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

4.  Dissociation of impulsive traits by subthalamic metabotropic glutamate receptor 4.

Authors:  Lukasz Piszczek; Andreea Constantinescu; Dominic Kargl; Jelena Lazovic; Anton Pekcec; Janet R Nicholson; Wulf Haubensak
Journal:  Elife       Date:  2022-01-04       Impact factor: 8.140

5.  Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations.

Authors:  G Mannaioni; V Carlà; F Moroni
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones.

Authors:  C H Davies; V R Clarke; D E Jane; G L Collingridge
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

7.  Coupling of metabotropic glutamate receptors to phosphoinositide mobilisation and inhibition of cyclic AMP generation in the guinea-pig cerebellum.

Authors:  K E Neil; D A Kendall; S P Alexander
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

Review 8.  Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.

Authors:  Paulina Cieślik; Joanna M Wierońska
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 9.  The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.

Authors:  Rebecca K Senter; Ayan Ghoshal; Adam G Walker; Zixiu Xiang; Colleen M Niswender; P Jeffrey Conn
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.